Switch to:
More From Other Websites
Theravance to Report Second Quarter 2014 Financial Results on August 6, 2014 Jul 29 2014
[$$] At Theravance, It's Hard to Breathe Easy Jul 25 2014
Theravance (THRX) Is in Oversold Territory: What's Next? Jul 25 2014
Theravance downgraded at BofA/Merrill Jul 24 2014
Why A Short Covering Rally Might Come for Theravance (THRX) Stock Jul 22 2014
UPDATE: Morgan Stanley Reiterates On Theravance As Slow Trends Weigh On Value Jul 21 2014
Theravance/Glaxo Commence Global Late stage Study on COPD Jul 16 2014
THERAVANCE INC Files SEC form 8-K, Other Events Jul 16 2014
GSK and Theravance announce initiation of phase III programme with fixed dose triple combination... Jul 16 2014
GSK and Theravance Announce Initiation of Phase III Programme With Fixed Dose Triple Combination... Jul 16 2014
Break Up Bonanza Jul 09 2014
THERAVANCE INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 09 2014
Glaxo/Theravance Drug Gets Japanese Approval Jul 07 2014
THERAVANCE INC Files SEC form 8-K, Other Events Jul 07 2014
Glaxo, Theravance announce Japanese approval for Anoro Ellipta Jul 07 2014
Anoro(R) Ellipta(R) (Umeclidinium/Vilanterol) Gains Approval in Japan for the Treatment of COPD Jul 07 2014
Theravance, Inc. Appoints Theodore J. Witek, Jr. As Senior VP, Corporate Partnerships, Clinical And... Jul 02 2014
Theravance, Inc. Appoints Theodore J. Witek, Jr. as Senior Vice President, Corporate Partnerships,... Jul 02 2014


Add Notes, Comments or Ask Questions

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide